+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hansenula anomala fungemia in an infant with gastric and cardiac complications with a review of the literature

Hansenula anomala fungemia in an infant with gastric and cardiac complications with a review of the literature

European Journal of Epidemiology 8(2): 305-308

A 6-month-old female infant, with a birth weight of 2.74 kilograms, was born with multiple congenital abnormalities, including gastric and gastrointestinal defects. She was admitted to the hospital with hematemesis. The patient could not be fed orally, and parenteral nutrition was initiated through a central venous catheter. Following pyloroplasty, she developed superior vena cava syndrome, renal disfunction and episodes of sepsis. Stool and respiratory specimens were negative for fungi, but for blood cultures yielded Hansenula anomala var. anomala. Cultures for fungi from intravenous catheter tips were negative. The baby was treated with amphotericin B (am B) and 5-fluorocytosine (5-FC), (amB; 0.1 mg/kg body weight and 5-FC, 100 mg, q.i.d.). The minimal inhibitory concentrations of am B, 5-FC, am B + 5-FC (1:1, W:W) and fluconazole to H. anomala were 1.56, less than 0.195, 1.56, and 1.56 .mu.g, respectively. Following antifungal therapy and removal of the catheter, the patient tolerated oral feeding and, at the time of discharge, her weight had increased to 4.91 kg. This report H. anomala as an opportunistic yeast pathogen for the first time in Alberta, Canada. Previously published cases of H. anomala infections are reviewed.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 002123169

Download citation: RISBibTeXText

PMID: 1644153

DOI: 10.1007/bf00144819

Related references

Hansenula anomala Fungemia in an Infant with Gastric and Cardiac Complications with a Review of the Literature. European Journal of Epidemiology 8(2): 305-308, 1992

Hansenula anomala Fungemia. Infectious Disease in Clinical Practice 19(3): 167-170, 2011

Fungemia due to Hansenula anomala. New York State Journal of Medicine 86(10): 541-542, 1986

Hansenula anomala fungemia. Reviews of Infectious Diseases 10(6): 1182-1186, 1988

Fungemia by Hansenula anomala. Revista Argentina de Microbiologia 35(1): 54-56, Enero-Marzo, 2003

Catheter-related fungemia by Hansenula anomala. Archives of Internal Medicine 149(3): 709, 713-709, 713, 1989

Fungemia caused by Hansenula anomala: successful treatment with fluconazole. Internal Medicine 31(5): 622-624, 1992

Neonatal fungemia caused by Hansenula anomala: a case report. Journal of Microbiology, Immunology, and Infection 33(4): 267-270, 2001

Hansenula anomala fungemia in a patient with acute myelocytic leukemia. Japanese Journal of Medical Mycology 34(4): 451-457, 1993

Catheter-related fungemia by Hansenula anomala in an intensive care unit. Journal de Mycologie Medicale 2(4): 220-222, 1992

Breakthrough fungemia due to Hansenula anomala in a leukemic patient successfully treated with amphotericin B. ChemoTherapy 42(2): 157-158, 1996

Breakthrough fungemia due to Hansenula anomala in a leukemia patient successfully treated with amphotericin B. Journal of ChemoTherapy 8(1): 85-86, 1996

Hansenula anomala fungemia in a patient undergoing IVH-treatment with ascending colon carcinoma. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 70(2): 198-205, 1996

Hansenula anomala: a new fungal pathogen. Two case reports and a review of the literature. Archives of Internal Medicine 148(5): 1210-1213, 1988

Isolation of the flavodehydrogenase domain of hansenula anomala flavocytochrome b 2 after mild proteolysis by a hansenula anomala proteinase. European Journal of Biochemistry 182(1): 67-76, 1989